Fig. 2From: A narrative review of estimands in drug development and regulatory evaluation: old wine in new barrels?Flow diagram detailing the identification, selection and inclusion of disease guidelines and approved products for data extraction and interpretation. *one approved product= one sponsor documentation and one corresponding set of regulatory questionsBack to article page